Pratt Collard Advisory Partners’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Pratt Collard Advisory Partners’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,300	Closed	-$323K	–	112
2019 Q1	$323K	Hold	6,300	–	–	0.26%	83
2018 Q4	$296K	Hold	6,300	–	–	0.27%	79
2018 Q3	$353K	Sell	6,300 -600	-9%	-$32.8K	0.28%	85
2018 Q2	$348K	Hold	6,900	–	–	0.3%	85
2018 Q1	$339K	Hold	6,900	–	–	0.3%	85
2017 Q4	$355K	Buy	+6,900	New	+$355K	0.29%	84

Other funds holding IHE

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Biegel & Waller Columbia, Maryland $179M AUM 1.6% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pratt Collard Advisory Partners's IHE Position: Q2 2019 in Review

Pratt Collard Advisory Partners sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2019, closing a stake of 6,300 shares — an estimated $323K sold.

Pratt Collard Advisory Partners first reported a position in IHE in Q4 2017 and held it in 6 quarters. The position peaked at $355K in Q4 2017. 87 funds tracked by Wall St. Rank hold IHE as of Q2 2019.

Pratt Collard Advisory Partners reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2019 after selling out during the quarter.
Pratt Collard Advisory Partners sold 6,300 iShares US Pharmaceuticals ETF shares in Q2 2019, an estimated $323K.
Pratt Collard Advisory Partners first reported a position in iShares US Pharmaceuticals ETF in Q4 2017 and held it in 6 quarters.
Pratt Collard Advisory Partners's iShares US Pharmaceuticals ETF position peaked at $355K in Q4 2017.
87 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2019.

Based on Pratt Collard Advisory Partners's 13F filing for Q2 2019, filed 16 Jul 2019.